The Situation
A leading pharmaceutical company sought to deepen its understanding of the rapidly evolving insulin market and prepare for anticipated new market entrants. To support future portfolio and commercialization decisions, the organization needed a partner that could deliver continuous, validated competitive intelligence, combining up-to-date market tracking, expert insights, and clear strategic implications.
The Solution
Sedulo designed and executed a comprehensive intelligence program integrating ongoing monitoring, primary intelligence, and strategic landscape development.
Ongoing Competitor Monitoring
Sedulo implemented proactive tracking and alerting across insulin innovators and biosimilars, monitoring developments, regulatory filings, launch activity, commercialization and go-to-market strategies, messaging and positioning, portfolio direction, and marketing tactics. The team also monitored emerging developers of biosimilars, biologics, and disease-modifying therapies. For Phase 3+ competitors, Sedulo delivered comprehensive summaries of earnings calls and financial conference presentations.
Comprehensive Primary Intelligence
To address key knowledge gaps and validate secondary findings, Sedulo conducted continuous primary intelligence using its Persistent Source Network™, engaging high-value industry sources to uncover deeper insights into strategies, timelines, and decision drivers.
Insulin Landscape Reports and Quarterly Refreshes
Sedulo synthesized learnings from secondary research and primary intelligence into an executive-ready Insulin Landscape Report. Using its Four-I’s process, Sedulo transformed raw information into prioritized insights and strategic implications, supported by data visualization and competitive analysis tools. Quarterly refreshes ensured the landscape remained current and decision-ready.
The Impact
The client gained a clear, validated, and continuously updated view of the insulin competitive landscape across innovators, biosimilars, and emerging therapies. Sedulo’s program enabled proactive scenario planning, stronger portfolio and commercialization decision-making, and greater confidence in preparing for new market entrants.